Skip to content
Private Equity FundPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 15 SOURCES

TechLife Capital

Also known as TechLife, Tech Life Capital, TechLife Digital

Paris growth equity manager (AMF-authorised 2019) investing €5–50M, majority or minority, in profitable French healthcare, technology and healthtech companies; more than €100M under management (2023).

HEADQUARTERS
Paris, France
FOUNDED
2019
AUM
€100M (2023)
OUTSIDE CAPITAL
Yes
TEAM LISTED
4 people

Focus

STAGES
GrowthBuyout
SECTORS
HealthTechSoftware & SaaS
ASSET MIX
Private equity
GEOGRAPHY
FranceEurope

Overview

TechLife Capital is a growth equity fund managed by an independent AMF-authorised management company founded by three partners with corporate and private equity backgrounds in healthcare and technology. It invests €5M to €50M, as majority or minority shareholder, in profitable French companies in nine sectors across healthcare (pharma, medical services, medical devices), technology (software, services, solutions) and healthtech. It works with 10 operating partners and holds the French Ministry of Economy's Tibi innovation-financing label. In March 2023 it reported more than €100M under management.

Investment thesis

Proactive investigation of pre-identified market verticals with accelerating demand and fragmented supply in healthcare, technology and healthtech; profitable French companies with a proven model aiming to double in size and expand internationally through organic growth and acquisitions; flexible structuring (new equity or secondary, majority or minority).

PORTFOLIO (10)

  • Ad Scientiam
    HealthTech · since 2025
  • Groupe Créative
    Software & SaaS · since 2025
  • Evolutis
    HealthTech · since 2023
  • CNSI
    Software & SaaS · since 2023
  • Quinten
    Artificial Intelligence · since 2022
  • Mitem Pharma
    Biotech & Life Sciences · since 2022
  • XPath Groupe
    HealthTech
  • Flash Therapeutics
    Biotech & Life Sciences
  • MyData-Trust
    HealthTech
  • Maxxing
    Software & SaaS · exited (merger with Optimix, July 2025)

People

  • Jacques Rossignol
    Managing Partner & Co-Founder · source
  • Grégoire Cayatte
    Managing Partner & Co-Founder · source
  • Henry Huyghues Despointes
    Senior Partner & Co-Founder · source
  • Jean-Max Demiautte
    Principal · source

Links

Frequently asked questions

TechLife Capital is a private equity fund based in Paris, France, founded in 2019.

Yes. TechLife Capital invests its own capital in private companies.

TechLife Capital invests at Growth and Buyout stages in HealthTech and Software & SaaS.

TechLife Capital's stated ticket size is €5M–€50M.

Key people at TechLife Capital include Jacques Rossignol (Managing Partner & Co-Founder), Grégoire Cayatte (Managing Partner & Co-Founder), Henry Huyghues Despointes (Senior Partner & Co-Founder) and Jean-Max Demiautte (Principal).

TechLife Capital's investments include Ad Scientiam, Groupe Créative, Evolutis, CNSI, Quinten, Mitem Pharma, XPath Groupe and Flash Therapeutics, among others.

The most recent publicly reported investment by TechLife Capital is Ad Scientiam (Growth equity (reference shareholder)), announced in Nov 2025.

Yes. TechLife Capital manages capital from outside investors.